↓ Skip to main content

CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

Overview of attention for article published in BMC Cancer, June 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
51 Mendeley